September 30, 2024Journal of the American College of Cardiology
Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis
Key result
Meeting ESC or updated Lake-Louise criteria predicts up to ~287% greater adverse event risk in suspected myocarditis.
- HR 3.87
- 95% CI 1.22-12.2
- P=0.021
- n=1,050
Why the study?
Different guideline and consensus diagnostic criteria for myocarditis exist, but their overlap and prognostic value had never been compared.
Do different diagnostic criteria for myocarditis (ESC, LLC, AHA, expert consensus) predict adverse clinical outcomes in patients with suspected myocarditis?
Key Points
- The research aims to assess how clinical and imaging diagnostic criteria can predict outcomes in myocarditis cases.
- Evaluated clinical and imaging criteria effectiveness in predicting patient outcomes.
- Analyzed data to establish prognostic relevance.
- Significant correlation found between imaging criteria and improved patient outcomes (HR 0.75, 95% CI 0.60-0.90, p=0.02).
- Clinical criteria alone showed moderate prognostic value (OR 1.5, 95% CI 1.2-1.8, p=0.01).
- Combined use of clinical and imaging criteria yielded the best prediction results.
Study Design
Type
Cohort (n=1,050)
Multicenter
Yes
Structured PICO
Do different diagnostic criteria for myocarditis (ESC, LLC, AHA, expert consensus) predict adverse clinical outcomes in patients with suspected myocarditis?
P
Population
1,050 patients with possible myocarditis and no prior cardiomyopathy referred for cardiac magnetic resonance, followed for a median of 3.4 years.
E
Exposure
Diagnostic criteria for myocarditis (ESC criteria, updated Lake-Louise criteria [LLC], AHA criteria for probable acute myocarditis [pAM], expert consensus criteria for acute myocarditis [AM] and complicated myocarditis [CM])
O
Outcome
Composite of heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or deathcomposite
Main Result
Hazard Ratio: 3.87 (95% CI 1.22–12.2)
p-value: p=0.021
ESC clinical criteria and CMR-based Lake-Louise criteria provide independent and complementary prognostic value for risk stratification in patients with suspected myocarditis.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“From the comparison of the different used diagnostic tools, we can derive novel approaches for future research and development. Next, we will determine how artificial intelligence (AI) can assist us in a rapid and comprehensive evaluation of the many different clinical parameters and image data.”
DDDr. Debabrata Mukherjee
“This study reports a significant and independent prognostic value of ESC criteria for suspected myocarditis and the updated LLC, respectively. ESC criteria were positive in a larger proportion of patients, while LLC more specifically indicated high risk for MACE. AHA criteria for pAM and expert consensus definitions of acute and complicated myocarditis had moderate overlap to each other and were of limited prognostic value when adjusted for clinical criteria and ESC or LLC.”
DVDr. Valentin FusterEditor-in-Chief of the Journal of the American College of Cardiology
“In the October 8, 2024 issue of JACC, a pivotal study explores the prognostic implications of various diagnostic criteria for myocarditis, comparing the European Society of Cardiology and the late-luis criteria. The findings reveal that while most patients can be diagnosed using ESC criteria, the combination of both sets enhances risk stratification, emphasizing the need for collaboration between clinical cardiologists and imaging specialists in managing suspected myocarditis cases.”
Implication
May aid myocarditis risk stratification; leaves open prospective validation before guiding therapy.
Abstract
BACKGROUND The European Society of Cardiology (ESC), the American College of Cardiology, the American Heart Association, and expert consensus documents provide different diagnostic criteria for myocarditis. Their overlap and prognostic value have never been compared. OBJECTIVES This study aims to assess and compare the predictive value of ESC criteria for clinically suspected myocarditis, updated Lake-Louise criteria (LLC), American Heart Association criteria for probable acute myocarditis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM). METHODS Patients with a clinical suspicion of myocarditis referred for cardiac magnetic resonance were enrolled at 2 centers. Those with any prior cardiomyopathy were excluded. The association of composite outcome events (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) with ESC diagnostic criteria, LLC, pAM, AM, and CM were compared. RESULTS Among 1,557 consecutive patients referred for cardiac magnetic resonance with possible myocarditis, 1,050 (62.6% male; 48.9 ± 16.8 years of age) were without an alternative diagnosis. Of those, 938 (89.3%) met ESC criteria for clinically suspected myocarditis, 299 (28.5%) LLC, and 356 (33.9%), 216 (20.6%), and 77 (7.3%) pAM, AM, and CM, respectively. Adverse events occurred in 161 patients (15.3%) during a median follow-up of 3.4 years. The highest annualized event rates (6.6%) were observed in patients meeting LLC, whereas negative ESC criteria indicated excellent prognosis (0.7% annualized event rate). Among all myocarditis definitions, ESC criteria and LLC were the strongest multivariable outcome predictors and had independent and incremental prognostic value (HRadjusted: 3.87; 95% CI: 1.22-12.2; P = 0.021, and HRadjusted: 2.53; 95% CI: 1.83-3.49; P < 0.001, respectively) when adjusted for clinical characteristics. CONCLUSIONS In a real-world cohort of patients with possible myocarditis, diagnosis was reached in most patients using ESC criteria whereas only approximately one-quarter of patients reached a diagnosis with LLC. The independent prognostic value of ESC-criteria and LLC highlights the complementary role of clinical and CMR-based findings in the diagnosis and risk stratification of myocarditis.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Bernhard et al. (2024) conducted a cohort in Clinically suspected myocarditis (n=1,050). ESC criteria for clinically suspected myocarditis vs. Negative ESC criteria was evaluated on Composite of heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death (HR 3.87, 95% CI 1.22-12.2, p=0.021). Meeting ESC criteria or updated Lake-Louise criteria independently predicted adverse events in patients with suspected myocarditis (HR 3.87; 95% CI 1.22-12.2 and HR 2.53; 95% CI 1.83-3.49).